Table 3. Adverse drug reactions occurred after a single administration of tenofovir disoproxil phosphate (292 mg) and tenofovir disoproxil fumarate (300 mg).
| Adverse events | Tenofovir disoproxil phosphate (n = 38) | Tenofovir disoproxil fumarate (n = 37) | Total (n = 38) |
|---|---|---|---|
| Total | 2 (5.26) [3] | 2 (5.41) [4] | 4 (10.53) [7] |
| Dyspepsia | 0 (0.00) [0] | 1 (2.70) [1] | 1 (2.63) [1] |
| Diarrhoea | 1 (2.63) [1] | 0 (0.00) [0] | 1 (2.63) [1] |
| Headache | 1 (2.63) [1] | 2 (5.41) [2] | 3 (7.89) [3] |
| Ocular discomfort | 0 (0.00) [0] | 1 (2.70) [1] | 1 (2.63) [1] |
| Myalgia | 1 (2.63) [1] | 0 (0.00) [0] | 1 (2.63) [1] |
Percentages are based on the subjects within each treatment group. Data are presented as number (%) [case].